Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2005
09/21/2005CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671392A Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
09/21/2005CN1671389A 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219779C Solvates of pymetrozine
09/21/2005CN1219778C Quinacridone derivant and application in organic electroluminescent device thereof
09/21/2005CN1219768C Quinoline derivatives as inhibitors of MEK enzymes
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/20/2005US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005US6946483 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
09/20/2005US6946479 for treatment of microbial infections
09/20/2005US6946478 Compounds
09/20/2005US6946477 Analgesics; therapy for drug abruse
09/20/2005US6946476 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes
09/20/2005US6946468 that inhibit farnesylation of mutant ras gene products; cancer; (2)-2-(2-methoxy-ethyl)-1-((cis)-3-sulfanyl-pyrrolidin-2-ylmethyl)-4-naphthoyl-piperazine
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946005 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2274946C Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/20/2005CA2125978C Improvements in chemical compounds
09/15/2005WO2005085387A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085242A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005WO2005085239A2 PYRROLE-DERIVATIVES AS FACTOR Xa INHIBITORS
09/15/2005WO2005085238A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
09/15/2005WO2005085236A2 Caspase inhibitors and uses thereof
09/15/2005WO2005085234A2 Bycyclic anthranilamide derivatives useful as insecticides
09/15/2005WO2005085233A1 Synthetic nanopores for dna sequencing
09/15/2005WO2005085232A1 Hydantoin derivatives for use as tace and aggrecanase inhibitors
09/15/2005WO2005085231A1 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
09/15/2005WO2005085230A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
09/15/2005WO2005085229A1 Crystal forms of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
09/15/2005WO2005085228A1 Cycloalkanopyridine derivative
09/15/2005WO2005085227A1 Inhibitors of akt activity
09/15/2005WO2005085226A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/15/2005WO2005085225A1 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085209A1 Basic amine compound and use thereof
09/15/2005WO2005085204A1 Process for producing nitrogenous 5-membered cyclic compound
09/15/2005WO2005085202A1 Pyridinamide derivative as kinase inhibitors
09/15/2005WO2005085201A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085198A2 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
09/15/2005WO2005085194A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005084672A1 Selected cgrp-antagonists, method for the production and use thereof as medicaments
09/15/2005WO2005084649A1 Stable capsule preparation
09/15/2005WO2005084395A2 Method of stabilization of functional nanoscale pores for device applications
09/15/2005WO2005084104A2 Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/15/2005WO2005068433A9 Benzimidazole derivatives
09/15/2005WO2005059037B1 Reagent for detecting an analyte
09/15/2005WO2005056520A8 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005054430A3 Hepatitis c virus inhibitors
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049604A3 Antithrombotic aromatic ethers
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005WO2005046578A3 Isoquinolinone potassium channel inhibitors
09/15/2005WO2005037832B1 Azabicycyclic compounds for relieving pain and treating central nervous system disorders
09/15/2005WO2005000404A3 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
09/15/2005WO2004112704A3 Substituted piperidine compounds and methods of their use
09/15/2005WO2004099170A3 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
09/15/2005WO2004096792A3 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
09/15/2005WO2004091514A3 Cgrp receptor antagonists
09/15/2005WO2004080971A8 Tetrahydroquinoline derivatives useful as serine protease inhibitors
09/15/2005US20050203301 Processes for producing 7-isoindoline-quinolone carboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient
09/15/2005US20050203289 Functional biopolymer modification reagents and uses thereof
09/15/2005US20050203286 Environmental protection series of reactive dyestuffs and their use
09/15/2005US20050203159 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
09/15/2005US20050203155 Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections
09/15/2005US20050203150 Compounds, compositions and methods for inhibiting or treating HIV-1
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005US20050203141 Polymorphic forms 2 and 3 of bilastin is transformed into polymorph 1, which is very stable and is not transformed into any of the other polymorphs 2 and 3; allergic reactions, pathological processes mediated by histamine
09/15/2005US20050203138 Biphenyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders
09/15/2005US20050203116 Desloratadine salts,process for their synthesis and pharmaceutical compositions thereof
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203113 Compounds and method for the treatment of overactive bladder
09/15/2005US20050203110 KINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUOROPHENYL)-n-3 -FLUOROPYRROLIDIN-3-YL-2-HYDROXYMETHYL-2-PHENYL-2,5-DIHYDRO-1n-PYRROL-1-CARBOXAMIDE
09/15/2005US20050203104 Cycloalkyl - containing 5-acylindolinones, the preparation thereof and their use as medicaments
09/15/2005US20050203101 Benzimidazole quinolinones and uses thereof
09/15/2005US20050203098 Use of tyrosine kinase inhibitors for treating substance use disorders
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 1080